SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas thruster-equipped Roadster reveal is driving attention, with some traders praising the engineering and speculating about deeper TeslaSpaceX ties. Others dismiss the demonstration as a publicity spectacle, questioning whether the vehicle can reach production, be street-legal, or generate meaningful revenue.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns over CoreWeaves heavy borrowing and stressed bond prices have fueled a sharp selloff, with traders debating whether AI infrastructure demand can outweigh refinancing risks. Some credit the rebound to Nvidia CEO Jensen Huangs reassurance about improving finances, while skeptics say the debt concerns remain unresolved.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is drawing attention after a rebound from a prolonged rare-earth-sector selloff, with traders debating whether oversold conditions and heavy short interest could support a sustained recovery or only a temporary bounce. Bulls point to U.S. government backing and domestic magnet production plans, while skeptics cite dilution risk, cash burn, delayed production and execution concerns.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows AI Passport launch, with NVIDIA as a partner, and EmployeeWorks upgrades have focused attention on its push to govern and deploy enterprise AI agents. Traders are generally bullish on the AI opportunity and recent analyst upgrades, while debating whether the stock can sustain its advance through resistance near $150.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Encouraging VS-7375 clinical data, including a 50% confirmed response rate in a small second-line pancreatic cancer cohort and an FDA-aligned Phase 3 path, are driving attention to Verastems KRAS G12D program. Traders are broadly optimistic about its potential across cancers, while weighing the early-stage evidence and shareholder dilution from a large offering.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is drawing attention as shares reach record and 52-week highs amid a rotation toward defensive healthcare stocks and continued breakout momentum. Traders are mostly upbeat, though some warn the stock looks extended and watch for a pullback or a failure to hold breakout levels.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Verastems VS-7375 clinical update is driving comparisons with RVMD, with traders pointing to early activity and tolerability signals at a much lower valuation while debating whether it could challenge RVMD in KRAS G12D cancers. Others emphasize RVMDs approved therapy and more advanced pipeline as advantages; claims that VS-7375 is superior remain speculative.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP is drawing attention amid a broad selloff in rare-earth and critical-minerals stocks, with traders debating whether the weakness is a buying opportunity or reflects persistent concerns about financing, profitability and macro conditions. Long-term bulls point to U.S. efforts to build domestic magnet supply and reduce reliance on China, while uncertainty around U.S.-China trade talks adds to near-term sentiment swings.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

YARTEMLEAs stronger-than-expected commercial launch and a Cantor Fitzgerald upgrade are driving attention, with traders focused on expanding U.S. adoption and reimbursement support as potential growth drivers. Optimism is tempered by debate over the unresolved European review and whether sales momentum can justify the stocks rerating.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention for strong performance and perceived resilience as traders describe a rotation from tech and semiconductors toward value and defensive dividend stocks. Long-term holders welcome its income and stability, while others question whether rising Treasury yields or the funds run-up could limit further gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best-Performing Leveraged Single-Stock ETFs of Last Week 

Some single-stock ETFs soared last week as strong earnings, a rebound in tech and easing rate-hike fears fueled outsized gains.

ETF Opportunities Trust - T-REX 2X Long AXTI Daily Target ETF

Neutral Sentiment

50bps hike

25bps hike

No change

Rate cut

September CPI rose 0.6% from the prior month to 3.7% annually, while producer prices jumped 6.3% year-over-year, the biggest gain since 2022, putting the Federal Reserve's October 27-28 meeting squarely in focus after its first rate hike in three years last month. What does the Fed do at its October meeting? Vote and explain your reasoning in the comments.

September CPI hit 3.7% and PPI jumped 6.3%, both hotter than expected. What does the Fed do at its October meeting?

Feed

News

Sentiment

Fundamentals

Info

AXTU ETF Opportunities Trust - T-REX 2X Long AXTI Daily Target ETF

Fundamentals

Latest AXTU News